Navigation Links
Feinstein Institute Scientist Wins Crafoord Award from Royal Swedish Academy of Sciences for Arthritis Research
Date:1/19/2013

MANHASSET, NY (PRWEB) January 19, 2013

The Royal Swedish Academy of Sciences announced today that Peter K. Gregersen, MD, a scientist at The Feinstein Institute for Medical Research, will receive the prestigious Crafoord Prize for his genetic research in the area rheumatoid arthritis.

Dr. Gregersen, center head of the Feinstein Institute's Robert S. Boas Center for Genomics and Human Genetics in Manhasset, NY, will be formally presented with the award on May 2 by the King of Sweden, Carl XVI Gustaf.

Dr. Gregersen and two collaborators, Robert Winchester, MD, professor of medicine in the Division of Rheumatology at New York Presbyterian Hospital, and Lars Klareskog, MD, a professor at Stockholm's Karolinska Institute, are being honored for their discoveries concerning the role of different genetic factors and their interactions with environmental factors in the pathogenesis, diagnosis and clinical management of rheumatoid arthritis," the Royal Swedish Academy of Sciences said in announcing its Crafoord Prize in Polyarthritis.

“The knowledge acquired by the 2013 Crafoord Laureates opens new possibilities for the prevention and better treatment of rheumatoid arthritis. Their focused detective work has resulted in a hypothesis that the disease arises from the interplay between genetic inheritance and environmental influences,” the Royal Academy said of Drs. Gregersen, Winchester and Klareskog. “According to this premise, joint problems from rheumatoid arthritis may start in another part of the body: the lungs.”

Dr. Gregersen will split a $600,000 award with his two colleagues.

Dr. Gregersen has mounted collaborations across the world in an effort to expand the numbers of genetic specimens used to identify specific disease genes, with an emphasis on autoimmune disorders. The North American Rheumatoid Arthritis Consortium, directed by Dr. Gregersen, has identified several major risk genes for rheumatoid arthritis.

To see a video of Dr. Gregersen speaking about the Craaford Award and his rheumatoid arthritis research, click here.

Here is a link to a news release about the award issued this morning by the Royal Swedish Academy of Science: click here

About The Feinstein Institute for Medical Research Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in many areas including Parkinson's disease, Alzheimer’s disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, human genetics, pulmonary hypertension, leukemia, neuroimmunology, and medicinal chemistry. The Feinstein Institute, part of the North Shore-LIJ Health System, ranks in the top 5th percentile of all National Institutes of Health grants awarded to research centers. For more information visit http://www.FeinsteinInstitute.org

Read the full story at http://www.prweb.com/releases/2013/1/prweb10336613.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Feinstein Institute to receive grant to improve schizophrenia treatment
2. Feinstein Institute to Receive Grant from Centers for Medicare & Medicaid Services to Improve Schizophrenia Treatment
3. Feinstein Institute researchers discover that bean used in Chinese food could protect against sepsis
4. Feinstein announces submission of new drug application for diagnosing parkinsonian syndromes
5. Feinstein Institute researchers discover plant derivative
6. A Feinstein Institute for Medical Research Study Shows Early Cognitive Problems among Those Who Eventually Get Alzheimer's
7. David H. Koch donates $10 million to Mount Sinais Jaffe Food Allergy Institute
8. Bascom Palmer Eye Institute announces breakthrough for degenerative vision disorder
9. The Ludwig Institute for Cancer Research announces launch of iTeos Therapeutics SA
10. A North American first at the Montreal Heart Institute
11. UC Santa Barbaras Kavli Institute receives 2 grants to explore interface of physics and biology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... May 23, 2017 , ... ... and Clinical Integration company, announced today that its iClinic V12.2 solution has achieved ... Prevalidation. NCQA recently introduced PCMH 2017 standards which emphasize team-based care with ...
(Date:5/23/2017)... ... May 23, 2017 , ... New England Journal Of Medicine Confirms Viability ... Policy Response”, -The Rory Staunton Foundation Calls on Health & Human Services, Tom Price ... Sepsis ( http://www.rorystauntonfoundation.org ) today reported on a new study released on May 21, ...
(Date:5/23/2017)... ... May 23, 2017 , ... By all indications, and due ... County. While officials call for diligence, asking homeowners to scout for any open water ... concerns. Along with the annoying buzz of mosquitos is the buzz associated with potential ...
(Date:5/23/2017)... ... 2017 , ... Orbita’s Nathan Treloar will discuss the role of voice-powered healthcare ... Connected Health and IoT: Technology Innovators and Disruption , the workshop is part ... market research and consulting firm specializing in emerging consumer technology products and services. , ...
(Date:5/22/2017)... ... May 22, 2017 , ... The ... the scientific development, healthcare training and clinical application of medical infrared imaging, has ... to perform medical thermal imaging services. , The first new educational offering is ...
Breaking Medicine News(10 mins):
(Date:5/9/2017)... , May 9, 2017  Semler Scientific, ... provides technology solutions to improve the clinical effectiveness ... results for the first quarter ended March 31, ... products enable our customers to identify when preventive ... intervene before events like heart attacks or strokes ...
(Date:5/6/2017)... --  Provista , a proven leader in the supply chain ... Jim Cunniff as the company,s new president and ... to Provista, including most recently serving as the president and ... . He assumed his new role with Provista on May ... Provista," says Jody Hatcher , president, Sourcing and Collaboration ...
(Date:5/4/2017)... Inc. (" Fortuna "), a private, clinical-stage biotech company, ... for embryonic and fetal stem cells by using direct reprogramming ... announced today the launch of its Scientific Advisory ... Father Kevin FitzGerald , S.J., PhD; Col. (R) ... , PhD. "We are excited and honored to ...
Breaking Medicine Technology: